IMS Health Files for IPO
IMS Health has filed a registration statement with the US Securities and Exchange Commission
IMS Health, which provides information, services and technology for the healthcare industry, that allows them to measure and improve performance, has filed a registration statement with the U.S. Securities and Exchange Commission for proposed initial public offering of its common stock.
In the clinical trials area, IMS Health acquired both DecisionView and TTC in 2012. DecisionView provided software solutions for patient enrollment in clinical trials, and TTC benchmarking and analytics solutions for negotiating costs of clinical trials through its GrantPlan database.
The full relase can be read here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
